Longboard Pharmaceuticals Competitors and Similar CompaniesClear all
Longboard Pharmaceuticals's competitors and similar companies include Autolus.
 Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | |
Founding Date | Founding Date 2020 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ San Diego, US | Locations London, GB HQ London, GB |
Employees | Employees 5056% increase | Employees 647 |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) 1.2 b |
Financial | ||
Net income | Net income ($54.4m) (FY, 2023) | Net income ($287.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 281.7m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View company